| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 0 | 13.697 | 8.875 | 0 | 2.352 | 40 | 0 |
| Total Income - EUR | - | - | 0 | 0 | 13.697 | 15.427 | 0 | 2.352 | 40 | 0 |
| Total Expenses - EUR | - | - | 1.313 | 3.719 | 13.207 | 15.265 | 0 | 5.373 | 3.021 | 2.877 |
| Gross Profit/Loss - EUR | - | - | -1.313 | -3.719 | 491 | 162 | 0 | -3.021 | -2.981 | -2.877 |
| Net Profit/Loss - EUR | - | - | -1.313 | -3.719 | 354 | 77 | 0 | -3.091 | -2.981 | -2.877 |
| Employees | - | - | 0 | 1 | 2 | 2 | 0 | 1 | 0 | 0 |
Check the financial reports for the company - Dr.! And Ritair Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 32.711 | 29.348 | 31.488 | 0 | 25.632 | 22.935 | 20.202 |
| Current Assets | - | - | 44 | 26 | 11.457 | 4.481 | 0 | 5.898 | 5.515 | 1.811 |
| Inventories | - | - | 0 | 0 | 0 | 2.625 | 0 | 2.575 | 2.567 | 0 |
| Receivables | - | - | 0 | 0 | 13.697 | 413 | 0 | 2.455 | 64 | 116 |
| Cash | - | - | 44 | 26 | -2.240 | 1.442 | 0 | 868 | 2.883 | 1.695 |
| Shareholders Funds | - | - | -1.270 | -4.966 | -4.516 | -4.353 | 0 | -16.327 | -19.258 | -24.581 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 0 | 41 | 40 | 40 |
| Debts | - | - | 1.313 | 37.702 | 45.321 | 40.322 | 0 | 47.857 | 47.707 | 46.593 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1629 - 1629" | |||||||||
| CAEN Financial Year |
1629
|
|||||||||
Comments - Dr.! And Ritair Srl